Bonds Extend Selloff as BOJ Tweaks Yield Control: Markets Wrap
Bonds around the world extended a retreat as the Bank of Japan, so far a holdout on ultra-loose
2023-07-28 16:57
Astra Strikes $1 Billion Gene Therapy Deal With Pfizer
AstraZeneca Plc has agreed to buy a portfolio of rare disease gene therapies from Pfizer Inc. as the
2023-07-28 14:45
Sanofi Lifts Guidance on Dupixent, Covid Vaccine Sales
Sanofi raised its forecast for the year as the French drugmaker gains new patients for blockbuster drug Dupixent
2023-07-28 13:52
North Korea Economy Shrinks Again as Pandemic Impact Drags On
North Korea’s economy shrank for a third year as the pandemic continued to weigh on activity, but resurgent
2023-07-28 11:28
GSK Raises Outlook, Looks to New Medicines to Fuel Growth
GSK Plc raised its guidance for the year after a strong start to 2023 as it prepares to
2023-07-26 15:20
Bayer Slumps After Cutting Outlook on Weak Herbicide Pricing
Bayer AG fell after slashing its outlook for the year amid persistently low prices for agriculture products, including
2023-07-25 15:23
Pfizer Plant Damaged by Tornado May Be Offline for Weeks
The tornado that hit a Pfizer Inc. plant earlier this week left production areas relatively unscathed, alleviating some
2023-07-22 07:20
Stanford University President Quits After Problems Discovered in His Research
Stanford University President Marc Tessier-Lavigne is resigning after months of scrutiny over flaws in his scientific research, sparked
2023-07-20 07:22
Twitter’s Surge in Harmful Content a Barrier to Advertiser Return
Elon Musk's Twitter acquisition, and the series of content policy changes that ensued, has led to a dramatic
2023-07-20 05:21
J&J Must Pay $18.8 Million in California Talc-Cancer Trial
Johnson & Johnson was ordered to pay $18.8 million to a California man who blamed the company’s talcum-based
2023-07-19 09:23
Eye Disease Drugmaker’s Value Halved After Severe Reactions
Apellis Pharmaceuticals Inc. shares suffered their worst two-day drop on record after confirming reports that some patients experienced
2023-07-19 04:16
Novartis Raises Outlook, Plans Buyback of Up to $15 Billion
Novartis AG raised its profit outlook and announced plans to buy back as much as $15 billion in
2023-07-18 13:50